Vafidemstat

N/A

Report date: 2024/02/05 16:46:37
NME

Base Information

Drug NameVafidemstat
Drug Alias NameORY-2001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitorsMonoamine oxidase B inhibitors
TargetsMonoamine oxidase BLysine-specific histone demethylase 1
Therapy Area/IndicationsKabuki syndromeSchizophreniaBorderline Personality Disorder +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesSerbia +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOryzon Genomics Sa
China Registration ClassN/A

Develop Information

Active CompaniesOryzon Genomics Sa
Inactive CompaniesN/A
Active IndicationsKabuki syndromeSchizophreniaBorderline Personality Disorder
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksDrugBank